{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-003270","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2023-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.288742+00:00","generated_at":"2026-06-20T03:57:12.613944+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ensysce declares Series A Preferred dividend with 1,000 votes per 0.001 share, tied to reverse split vote","bullets":["Board declares dividend of 0.001 Series A Preferred share per common share; record date Feb 13, 2023.","Each 0.001 of a share carries 1,000 votes; voting limited exclusively to reverse split and adjournment proposals.","Preferred shares are non-transferable except with common; automatically redeemed if not voted at the meeting.","Liquidation preference of $0.0001 per share; no dividend or conversion rights; filing of Certificate of Designation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-003270","json":"https://secwatch.observer/filing/0001493152-23-003270.json","markdown":"https://secwatch.observer/filing/0001493152-23-003270.md","text":"https://secwatch.observer/filing/0001493152-23-003270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/0001493152-23-003270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T03:57:12.613944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"888793cf02000adb58818a9732d3fc948c178606","claim":"Ensysce Biosciences, Inc.: Creation of Series A Preferred Stock via a dividend declared on January 31, 2023, effective upon filing of a Certificate of Designation (effective 2023-01-31).","evidence_excerpt":"On January 31, 2023, the Board of Directors (the “Board”) of Ensysce Biosciences Inc. (the “Company”) declared a dividend of 0.001 of a share of Series A Preferred Stock, par value $0.0001 per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) to stockholders of record at 5:00 pm Eastern Time on February 13, 2023 (the “Record Date”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/0001493152-23-003270-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-01-31"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}